Anti-Human Complement Component C1q, PE (Clone MhC5B9) (mouse IgG1) (Special 100ug/0.5ml concentration)
|
Product Code:
|
CL7611PE-SP |
|
Supplier Name:
|
Cedarlane |
|
Size:
|
100 ug |
|
Data Sheet:
|
View Data Sheet |
|
Categories:
|
MhC5B9 |
Additional Product Details
|
Applications:
|
F |
|
Clone:
|
MhC5B10 |
|
Format:
|
PE |
|
Isotype:
|
Mouse IgG1 |
|
Specificity:
|
C1q |
|
Host:
|
Mouse |
|
Conjugate:
|
R-phycoerythrin |
|
Species Reactivity:
|
Human |
-
DescriptionCedarlane's Anti-Human Complement Component C1q Monoclonal Antibody detects the C1q portion of the macromolecular C1 complex. C1 exists in the serum and consists of C1q and 2 molecules each of C1r and C1s, held together in a complex (C1qr2s2) stabilized by Ca2+ ions. C1q specifically binds surface bound IgG and IgM to facilitate complement activation via the classical pathway. The C1q subunit is made up of an umbrella-like radial array of six chains, each of which has a globular head connected by a collagen-like arm to a central stalk. The C1q molecule is 460 kDa (hexamer of three pairs of chains; 22, 23, 24 kDa). Note that the specific epitope (subunit) which this antibody recognizes has not yet been determined.______________________________________________________________________________________________________Flow Cytometry Analysis

Balb/c mouse thymocytes incubated with anti-mouse CD90 (Thy 1.2) (clone: 5a-8) + fresh human serum + 5 mM EDTA were stained with anti-C1q (clone: MhC5B9) (filled histogram) or mouse IgG1 isotype control (open histogram).
-
References
1) Schuh R, Kremmer E, Ego E, Wasiliu M and Thierfelder S. (1992) Determination of monoclonal antibody specificity by immunoadsorption and western blotting. J Immunol Methods. 152(1): 59-67.
2) Zwirner J, Wittig A, Kremmer E, Gotze O. (1998) A novel ELISA for the evaluation of the classical pathway of complement. J. Immunol. Methods. 211: 183-190.
3) Nielsen C, Ostergaard O, Stener L, et al. (2012) Increased IgG on Cell-Derived Plasma Microparticles in Systemic Lupus Erythematosus Is Associated With Autoantibodies and Complement Activation. Arthritis and Rheumatism. 64(4):1227-36.

